| abstract |
Disclosed is a novel compound, and pharmaceutically acceptable salts thereof, useful in the treatment or prevention of diseases caused by inhibitory activity on glycine intake, such as schizophrenia, Alzheimer's disease, cognitive impairment, dementia, anxiety disorders (generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, post traumatic stress disorder, specific phobias, acute stress disorder etc.), depression, substance abuse, convulsions, tremors, pain, or sleep disorders. Disclosed are the compound represented by formula [I], and pharmaceutically acceptable salts thereof. |